Skip to Content

Spin-Off Companies

UBC has a world-class reputation for its commercialization activities, and the Michael Smith Laboratories is proud to be part of this recognized success. One of the university's most successful spin-off companies, Neuromed Pharmaceuticals (now Zalicus) started in the research laboratory of Dr. Terry Snutch. In 2006 Neuromed Pharmaceuticals entered into an almost half-a-billion dollar agreement with Merck & Co. in what was the largest licensing deal in Canada's biotech history. Research in the Michael Smith Laboratories is helping to transform promising science into product-driven deals.

1992Biomarin Pharmaceuticals (note: formerly Synapse Technologies)
1995Neuromed Technologies (acquired by Zalicus)
1998Raven Biotech. Inc.
2000TapImmune (formerly GeneMax Pharmaceuticals Inc.)
2002Inimex Pharmaceuticals Inc.
2010 Vedanta